Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016
Cash Flows From Operating Activities
Net loss	$ (2,555,802)	$ (781,432)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of leasehold improvements and equipment	396,000	234,408
Amortization of intangibles	148,005	63,116
Share-based compensation expense	1,210,508	930,026
Allowance for doubtful trade receivables	(547,811)	235,591
Gain from disposal of assets	(5,467,268)	0
Loss from disposal of equipment	4,649	0
Loss on debt extinguishment	0	313,099
Non-cash financing costs	89,481	94,080
Changes in operating assets and liabilities:
Trade receivables	1,491,529	(4,296,439)
Inventories	1,358,299	1,840,572
Prepaid expenses and other assets	(480,353)	(230,667)
Accounts payable	(1,735,361)	(2,125,180)
Accrued expenses	(43,796)	406,797
Customer deposits and other	(61,071)	5,613
Deferred rent	188,290	182,634
Due to officer	(32,500)	0
Net cash used in operating activities	(6,037,201)	(3,127,782)
Cash Flows From Investing Activities
Proceeds from disposal of assets, net of transaction costs	5,953,390	0
Purchases of leasehold improvements and equipment	(872,215)	(940,978)
Purchases of intangible assets	(183,958)	(205,000)
Net cash provided by (used in) investing activities	4,897,217	(1,145,978)
Cash Flows From Financing Activities
Proceeds from issuance of common stock, net of issuance costs	23,713,762	5,717,474
Proceeds from exercise of stock options	395,014	716,612
Payment of debt issuance cost	(49,279)	0
Principal payments on loan payable	0	(5,000,000)
Cash paid for debt extinguisment costs	0	(281,092)
Principal payments on capital leases	(562,309)	(164,150)
Net cash provided by financing activities	23,497,188	988,844
Net increase (decrease) in cash	22,357,204	(3,284,916)
Cash Beginning of Period	1,642,429	5,549,672
Cash Ending of Period	23,999,633	2,264,756
Supplemental Disclosures of Cash Flow Information
Cash payments for interest	43,912	251,231
Supplemental Schedule of Noncash Investing Activity
Noncash consideration transferred for the acquisition of Healthspan Research LLC	1,187,430	0
Capital lease obligation incurred for purchases of equipment	514,899	0
Receivable from disposal of assets held at escrow	750,000	0
Inventory supplied to Healthspan Research, LLC for equity interest, at cost	0	20,318
Retirement of fully depreciated equipment - cost	55,947	28,083
Retirement of fully depreciated equipment - accumulated depreciation	$ (55,947)	$ (28,083)